AI assistant
Adaptive Biotechnologies Corp — Director's Dealing 2019
Jun 27, 2019
31660_dirs_2019-06-26_8d4e86a5-9370-46a0-b419-e45106ede17c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2019-06-26
Reporting Person: SANG CHARLES (Sr VP, Clinical Diagnostics)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $6.32 | 2026-04-29 | Common Stock (100000) | Direct | |
| Stock Option (Right to Buy) | $6.55 | 2028-02-07 | Common Stock (250000) | Direct | |
| Stock Option (Right to Buy) | $7.27 | 2029-02-07 | Common Stock (75000) | Direct |
Footnotes
F1: The options vested with respect to 1/4 of such shares on April 11, 2017, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F2: The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F3: The options vest with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.